We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.53B
1-Year Est. Return 154.61%
This Fund
S&P 500
This Quarter Est. Return
+33.46%
1 Year Est. Return
+154.61%
3 Year Est. Return
+564.07%
5 Year Est. Return
+985.88%
10 Year Est. Return
–
AUM
$2.53B
AUM Growth
+$441M
Cap. Flow
+$174M
Cap. Flow %
6.85%
Top 10 Hldgs %
44.81%
Holding
120
New
30
Increased
23
Reduced
22
Closed
28

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$84.8M
2
AXSM icon
Axsome Therapeutics
AXSM
+$57.5M
3
EW icon
Edwards Lifesciences
EW
+$38.1M
4
ABT icon
Abbott
ABT
+$36.5M
5
UNH icon
UnitedHealth
UNH
+$31.5M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$49.3M
2
BTSG icon
BrightSpring Health Services
BTSG
+$38.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$30.6M
4
CNC icon
Centene
CNC
+$18.7M
5
FMS icon
Fresenius Medical Care
FMS
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 96.27%
2 Miscellaneous 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
51
Madrigal Pharmaceuticals
MDGL
$11.9B
$13.4M 0.53%
25,000
– –
PRAX icon
52
Praxis Precision Medicines
PRAX
$7.84B
$13.4M 0.53%
40,000
– –
ANRO icon
53
Alto Neuroscience
ANRO
$1.04B
$13.2M 0.52%
500,000
– –
MLYS icon
54
Mineralys Therapeutics
MLYS
$2.29B
$12.1M 0.48%
450,000
-300,000
-40% -$8.23M
XENE icon
55
Xenon Pharmaceuticals
XENE
$3.58B
$12.1M 0.48%
200,000
– –
ASND icon
56
Ascendis Pharma A/S
ASND
$14.8B
$12M 0.47%
45,000
-70,000
-61% -$16.4M
ACHC icon
57
Acadia Healthcare
ACHC
$2.62B
$11.8M 0.47%
400,000
+200,000
+100% +$5.13M
IRTC icon
58
iRhythm Holdings
IRTC
$3.64B
$10.7M 0.42%
+90,000
New +$10.5M
BHVN icon
59
Biohaven
BHVN
$1.96B
$10.4M 0.41%
700,000
-300,000
-30% -$3.23M
BEAM icon
60
Beam Therapeutics
BEAM
$2.51B
$10.3M 0.41%
300,000
– –
IART icon
61
Integra LifeSciences
IART
$1.25B
$9.88M 0.39%
+550,000
New +$7.69M
GEHC icon
62
GE HealthCare
GEHC
$30.1B
$9.6M 0.38%
+150,000
New +$9.86M
RGNX icon
63
Regenxbio
RGNX
$488M
$9.58M 0.38%
800,000
-700,000
-47% -$5.81M
ABSI icon
64
Absci
ABSI
$1.67B
$9.27M 0.37%
+800,000
New +$4.51M
BRKR icon
65
Bruker
BRKR
$9.78B
$9.03M 0.36%
+150,000
New +$7M
COR icon
66
Cencora
COR
$58.6B
$8.49M 0.34%
+30,000
New +$8.65M
COGT icon
67
Cogent Biosciences
COGT
$5.61B
$7.74M 0.31%
200,000
-150,000
-43% -$5.25M
ELVN icon
68
Enliven Therapeutics
ELVN
$3.28B
$7.61M 0.3%
+150,000
New +$6.37M
BIOA
69
BioAge Labs
BIOA
$324M
$7.35M 0.29%
+300,000
New +$5.42M
JAZZ icon
70
Jazz Pharmaceuticals
JAZZ
$15.4B
$7.23M 0.29%
+30,000
New +$6.57M
SANA icon
71
Sana Biotechnology
SANA
$882M
$6.98M 0.28%
2,000,000
-1,200,000
-38% -$3.87M
IVA
72
Inventiva
IVA
$796M
$5.75M 0.23%
1,520,000
+1,120,000
+280% +$5.38M
TARA icon
73
Protara Therapeutics
TARA
$194M
$5.73M 0.23%
1,500,000
-250,000
-14% -$1.19M
ALKS icon
74
Alkermes
ALKS
$6.85B
$5.24M 0.21%
+100,000
New +$3.91M
LBRX
75
LB Pharmaceuticals
LBRX
$1.2B
$4.87M 0.19%
150,000
– –
1 2
3
4 5

Similar funds

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.53B AUM 24.4% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.54B AUM 18.96% 1-Year Est. Return
QT
Quantbot Technologies New York $2.54B AUM 22.25% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.53B AUM 37.62% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.54B AUM 23.56% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.54B AUM 17.62% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.52B AUM 26.26% 1-Year Est. Return

Integral Health Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Integral Health Asset Management held 120 positions worth $2.53B, up 21% from $2.09B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management deployed $174M of net new capital in Q2 2026, opening 30 new positions and adding to 23 existing holdings. Its largest new stake was Abbott: 400,000 shares worth $36.3M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 90% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was BrightSpring Health Services, an estimated $38.9M trimmed.

  • Integral Health Asset Management's largest Q2 2026 buy was Abbott: 400,000 shares worth $36.3M.
  • Integral Health Asset Management added most to CVS Health in Q2 2026, an estimated $84.8M increase.
  • Integral Health Asset Management's biggest Q2 2026 reduction was BrightSpring Health Services, cutting an estimated $38.9M.
  • Integral Health Asset Management fully exited AstraZeneca in Q2 2026, selling an estimated $49.3M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $2.53B portfolio in Q2 2026.
  • Integral Health Asset Management opened 30 new positions and closed 28 in Q2 2026.
  • Integral Health Asset Management's portfolio value rose 21% quarter-over-quarter to $2.53B.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.